BDBM4612 1,6-naphthyridine deriv. 14::1-[7-amino-3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-yl]-3-ethylurea::N-[7-Amino-3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-yl]-N-ethylurea

SMILES: CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1

InChI Key: InChIKey=ANRWHDLTBMMQJD-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 4612   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Fibroblast growth factor receptor 1 (Homo sapiens (Human))	BDBM4612 (1,6-naphthyridine deriv. 14 | 1-[7-amino-3-(3,5-di...) Show SMILES CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1 Show InChI InChI=1S/C19H21N5O3/c1-4-21-19(25)24-18-15(7-12-10-22-17(20)9-16(12)23-18)11-5-13(26-2)8-14(6-11)27-3/h5-10H,4H2,1-3H3,(H2,20,22)(H2,21,23,24,25)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	29	n/a	n/a	n/a	n/a	7.4	25
University of Auckland					Assay Description IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...				J Med Chem 43: 4200-11 (2000) Article DOI: 10.1021/jm000161d BindingDB Entry DOI: 10.7270/Q2JW8C3G
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM4612 (1,6-naphthyridine deriv. 14 | 1-[7-amino-3-(3,5-di...) Show SMILES CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1 Show InChI InChI=1S/C19H21N5O3/c1-4-21-19(25)24-18-15(7-12-10-22-17(20)9-16(12)23-18)11-5-13(26-2)8-14(6-11)27-3/h5-10H,4H2,1-3H3,(H2,20,22)(H2,21,23,24,25)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
University of Auckland					Assay Description IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...				J Med Chem 43: 4200-11 (2000) Article DOI: 10.1021/jm000161d BindingDB Entry DOI: 10.7270/Q2JW8C3G
					More data for this Ligand-Target Pair
Platelet-derived growth factor receptor beta (Homo sapiens (Human))	BDBM4612 (1,6-naphthyridine deriv. 14 | 1-[7-amino-3-(3,5-di...) Show SMILES CCNC(=O)Nc1nc2cc(N)ncc2cc1-c1cc(OC)cc(OC)c1 Show InChI InChI=1S/C19H21N5O3/c1-4-21-19(25)24-18-15(7-12-10-22-17(20)9-16(12)23-18)11-5-13(26-2)8-14(6-11)27-3/h5-10H,4H2,1-3H3,(H2,20,22)(H2,21,23,24,25)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>5.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
University of Auckland					Assay Description IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...				J Med Chem 43: 4200-11 (2000) Article DOI: 10.1021/jm000161d BindingDB Entry DOI: 10.7270/Q2JW8C3G
					More data for this Ligand-Target Pair